SCHEMBL2481945

SCHEMBL2481945

Cc1cc(-c2ccccc2)cc(OC(=O)c2ccccc2)c1OC(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
SLC6A3 Q01959 1/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
ESR1 P03372 2/20 0.43
ESR2 Q92731 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 2/20 0.42
GAA P10253 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HTT P42858 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.41
MDM2 Q00987 1/20 0.41
JAK2 O60674 1/20 0.41
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2482229 0.84 MAPT (0.50) MAPTKMT2AMEN1SMN1; SMN2SLC6A3
SCHEMBL2508951 0.83 MAPT (0.47) MAPTKMT2AMEN1SMN1; SMN2SLC6A3
SCHEMBL13805553 0.83 TSHR (0.48) MAPTKMT2AMEN1SMN1; SMN2SLC6A3
SCHEMBL2479005 0.82 MAPT (0.46) MAPTKMT2AMEN1TP53SMN1; SMN2
SCHEMBL13104612 0.81 MAPT (0.50) MAPTKMT2AMEN1TP53SMN1; SMN2
SCHEMBL13657589 0.81 TSHR (0.47) MAPTKMT2AMEN1TP53SMN1; SMN2
Biphenyl SCHEMBL21880211 0.81 MAPT (0.45) MAPTKMT2AMEN1SMN1; SMN2TDP1
SCHEMBL14137285 0.81 MAPT (0.48) MAPTKMT2AMEN1SMN1; SMN2ESR1
SCHEMBL2480717 0.81 PDCD1 (0.44) MAPTKMT2AMEN1SMN1; SMN2SLC6A3
SCHEMBL17301233 0.81 PDCD1 (0.46) MAPTKMT2AMEN1SMN1; SMN2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT MAPT 2384/4885KMT2A 1611/4885MEN1 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.